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Abstract
Objectives. Innate lymphoid cells (ILCs) share many characteristics
with CD4+ T cells, and group 1 ILCs share a requirement for T-bet
and the ability to produce IFNc with T helper 1 (Th1) cells. Given
this similarity, and the importance of Th1 cells for protection
against intracellular protozoan parasites, we aimed to characterise
the role of group 1 ILCs during Plasmodium infection. Methods.
We quantified group 1 ILCs in peripheral blood collected from
subjects infected with with Plasmodium falciparum 3D7 as part of
a controlled human malaria infection study, and in the liver and
spleens of PcAS-infected mice. We used genetically-modified
mouse models, as well as cell-depletion methods in mice to
characterise the role of group 1 ILCs during PcAS infection.
Results. In a controlled human malaria infection study, we found
that the frequencies of circulating ILC1s and NK cells decreased as
infection progressed but recovered after volunteers were treated
with antiparasitic drug. A similar observation was made for liver
and splenic ILC1s in P. chabaudi chabaudi AS (PcAS)-infected mice.
The decrease in mouse liver ILC1 frequencies was associated with
increased apoptosis. We also identified a population of cells
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within the liver and spleen that expressed both ILC1 and NK cell
markers, indicative of plasticity between these two cell lineages.
Studies using genetic and cell-depletion approaches indicated that
group 1 ILCs have a limited role in antiparasitic immunity during
PcAS infection in mice. Discussion. Our results are consistent with
a previous study indicating a limited role for natural killer (NK)
cells during Plasmodium chabaudi infection in mice. Additionally,
a recent study reported the redundancy of ILCs in humans with
competent B and T cells. Nonetheless, our results do not rule out a
role for group 1 ILCs in human malaria in endemic settings given
that blood stage infection was initiated intravenously in our
experimental models, and thus bypassed the liver stage of
infection, which may influence the immune response during the
blood stage. Conclusion. Our results show that ILC1s are lost early
during mouse and human malaria, and this observation may help
to explain the limited role for these cells in controlling blood
stage infection.
Keywords: inflammation, natural killer cells, parasitic–protozoan.
INTRODUCTION
Innate lymphoid cells (ILCs) resemble T helper (Th)
cells in terms of their characteristic transcription
factors and functions.1 Groups 1, 2 and 3 ILCs
make up the ILC repertoire, and these groups are
similar to Th1, Th2 and Th17 cells, respectively. In
contrast to Th cells of the adaptive immune
system, ILCs do not express antigen-specific T-cell
receptors.2 ILCs have both protective and
pathogenic roles in infectious and inflammatory
diseases.3,4 However, a recent study has suggested
that ILCs are redundant in the presence of a
competent B and T-cell response in humans.5
Group 1 ILCs consist of conventional natural killer
(cNK) cells and ILC1s.1,6 These cell subsets share
common developmental requirements for the
transcription factor T-bet and their ability to
produce the pro-inflammatory cytokine IFNc.6
However, the relationship between these cells is
still widely debated. Liver ILC1s are a specialised
subset of group 1 ILCs also known as tissue-resident
NK (trNK) cells.7 Other ILC1s have also been
identified in the uterus,8 spleen,9 salivary gland,10
kidney,11 adipose tissue12 and gastrointestinal
tract.9 These different tissue-resident subsets have
unique cell surface phenotypes and functions.4,9,13
Malaria is a globally important infectious disease
caused by protozoan parasites belonging to the
genus Plasmodium. Following infection, a Th1-
dependent immune response can develop in the
mammalian host, aiding clearance of parasites via
IFNc-dependent mechanisms.14,15 IFNc production
by antigen-specific CD4+ T cells during P. chabaudi
chabaudi AS (PcAS) infection in mice has been
reported,16 and increased parasite growth was
observed following IFNc neutralisation.17 The
relationship between IFNc production and control
of parasite growth has also been reported in
humans during blood stage Plasmodium
falciparum (Pf) infection.18 Additionally, we
recently showed an inverse correlation between
IFNc levels and parasite burden during controlled
human malaria infection (CHMI) with Pf.19
However, the secretion of IFNc contributes to an
inflammatory environment that can also
contribute to pathology.18,20–24 While the adaptive
immune response generated in response to
Plasmodium infection has been well characterised,
less is known about the innate immune response
following infection. Early studies revealed that the
depletion of NK cells with anti-asialo GM1
antibody resulted in increased parasitaemia during
PcAS infection.25 However, the effects of this
treatment on dendritic cell (DC) function26 and the
depletion of other cell subsets, such as basophils,27
may impact the interpretation of these results. In
fact, depletion of NK cells in mice via
administration of anti-NK1.1 antibody resulted in
no effect on the course of P. chabaudi adami
556KA infection.28 However, evidence for direct
interactions between human NK cells and Pf
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parasitised red blood cells (pRBC) in vitro, which
stimulates production of IFNc, has been reported.29
Given that group 1 ILCs function like Th1 cells,
and little is known about their roles during
Plasmodium infection, we examined these cells, as
well as the more well-studied innate-like T cells
(including cd T cells,28 invariant natural killer
T (iNKT) cells30,31 and mucosal-associated invariant
T (MAIT) cells32) in volunteers infected with Pf in
CHMI studies. Concurrently, we also investigated
the role of ILC1s in C57BL/6J mice infected with
PcAS, which causes a chronic, nonlethal
infection.33 We report that cNK cells and ILC1s
had a limited role in controlling peripheral blood
parasitaemia in mice infected with PcAS. However,
we found a loss in circulating NK cells and ILC1s in
volunteers participating in CHMI studies with Pf,
which was independent of parasite burden. A
similar loss of ILC1s was also observed in the liver
and spleen of mice infected with PcAS.
Furthermore, we report a novel NK1.1+ NKp46+
population that expressed both the ILC1 marker
CD49a and the cNK marker DX5 (CD49b) in the
livers of PcAS-infected mice, suggesting plasticity
between these cell populations.
RESULTS
The frequency and number of ILC1s declined
during blood stage Pf infection
NK and cd T cells produce IFNc in response to Pf
infection.34–36 To gain a better understanding of
IFNc production by innate immune cells, including
more recently identified ILC1s and innate-like
T cells, we examined these cell populations during
an experimentally induced blood stage malaria
infection in healthy volunteers with no prior
exposure to malaria or residence in malaria-
endemic regions.37,38 Human PBMCs were isolated
from blood drawn prior to infection (day 0) and at
7 days postinfection (p.i.), prior to drug treatment
(Figure 1a). We then identified group 1 ILCs
(CD56 CD127+ T-bet+ ILC1s and NK cells), group 1
ILC-like cells (CD56+ CD127+ T-bet+) (Figure 1b and
Supplementary figure 1A), as well as innate-like
T cells (cd T cells [CD3+, cd TCR+], iNKT cells [CD3+,
CD1d PBS44 tetramer+] and MAIT cells [CD3+, CD8+,
CD161+, TCR Va7.2+]) (Supplementary figure 1B).
We found the frequency and number of NK
cells, CD56+ CD127+ ILC1s and cd T cells were
reduced at 7 days p.i., compared to day 0
(Figures 1d and e). NK cells and all innate-like T-
cell populations produced IFNc upon PMA +
ionomycin restimulation; however, only the
frequency of IFNc+ iNKT, cd T and MAIT cells was
significantly reduced at day 7, compared to day 0
(Figure 1f). The white blood cell count (WBC) in
volunteers was not significantly different
between days 0 and 7 p.i. (Figure 1c), indicating
that a general loss of blood leukocytes during
infection did not account for these results. When
the frequency and numbers of these cells were
examined in one cohort after volunteers were
treated with antiparasitic drug, we found they
had recovered and in some cases were increased,
relative to pre-infection levels (Table 1).
Parasite accumulation in volunteers, as
measured by the area under the curve (AUC) of
blood parasitaemia curves (Figure 1a), was plotted
against the frequency or cell number of each cell
subset shown in Figure 1 at day 7 p.i. to identify
any relationships with parasite burden. However,
no significant relationships were found for any ILC
or innate-like T cells (P > 0.05 for all cell subsets;
data not shown). Similar results were obtained
when the parasite multiplication rate (PMR) over
time in each volunteer was plotted against
corresponding ILC or innate-like T-cell frequencies
or cell number. Together, these results show the
frequency and cell number of group 1 ILCs were
reduced following first exposure to blood stage Pf
but this reduction was independent of parasite
burden or PMR and recovered following
antiparasitic drug treatment. These data suggest
that NK cells and ILC1s either have increased cell
death, decreased cell proliferation or sequester to
tissues following Pf infection.
A loss of liver trNK cells and splenic ILC1s
during PcAS infection
To further investigate ILCs in tissues during
malaria, we next employed a mouse model of
PcAS infection. A novel subset of liver ILC1s (trNK
cells) has been reported in mice and humans.7,39
We examined these cells, as well as splenic ILC1s,9
because of the importance of the liver and spleen
as blood filtering organs during Plasmodium
infection.40,41 We identified liver ILC1s that were
lineage (Lin; CD3, CD5, CD19)-negative, CD45+
NK1.1+ NKp46+ CD49a+ DX5 (Figure 2a). These
were distinct from splenic ILC1s, identified as Lin
CD45+ NK1.1+ NKp46+ Eomes CD127+9
(Figure 2b). We found a decrease in the frequency
and number of liver (Figure 2c) and spleen ILC1s
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Figure 1. ILC and innate-like T-cell frequencies decrease following P. falciparum infection. Representative blood parasitaemia curve over the first
7 days of infection from a single cohort (n = 6) (a). Group 1 ILC and group 1 ILC-like subsets were identified by flow cytometry as indicated in
the gating strategy (b). White blood cell counts for each patient at days 0 and 7 are depicted (c). The frequencies (d) and cell numbers (e) of
group 1 ILC, group 1 ILC-like and innate-like T-cell subsets are shown. The proportion of each subset producing IFNc is shown (f). The data from
b–f represent results from one to three cohorts (n = 8–14). Error bars represent the mean  standard deviation (SD) (a). Comparisons between
days 0 and 7 were made using the Wilcoxon (paired, nonparametric) test for NK cells and a two-way ANOVA with Sidak’s multiple comparisons
test for other subsets. *P < 0.05, **P < 0.01, ***P < 0.001.
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(Figure 2d) 5 days p.i. with PcAS, although
statistical differences were only reached in cell
frequencies (Figures 2c and d). In contrast, liver
cNK cells (NK1.1+ NKp46+ CD49a DX5+) increased
in cell number over this same time period
(Figure 2e).
ILC1s exhibit a more apoptotic phenotype
than cNK cells
One possible explanation for the reduced ILC1
frequency and number following PcAS infection
could be increased apoptosis. To test this, we
stained liver ILC1s ex vivo to assess Caspase-3/7
expression as a marker of apoptosis from days 1 to 4
p.i. (Figure 3a). Flow cytometry analysis revealed
approximately 20% of liver ILC1s expressing
Caspase-3/7 in na€ıve C57BL/6 mice (Figure 3b).
Following PcAS infection, the frequency of Caspase-
3/7-expressing ILC1s increased further at 2 days p.i.,
compared to na€ıve cells. Therefore, increased
apoptosis may at least partly explain the reduced
liver ILC1 frequency early after PcAS infection.
Emergence of a CD49a+ DX5+ double-
positive population
We also identified a population of cells within the
liver and spleen that were Lin CD45+ NK1.1+
NKp46+ CD49a+ DX5+ (herein referred to as the
CD49a+ DX5+ double-positive’ population)
(Figures 4a and b). This population was readily
detected 5 days p.i. and increased as infection
progressed (Figure 4c). This CD49a+ DX5+ double-
positive population was detected at lower
frequencies at 28 days p.i. when the ratio of ILC1s
to cNK cells resembled that of na€ıve samples,
although full recovery of ILC1 number or
frequency was not evident at this time point
(Figure 4c). Interestingly, the CD49a+ DX5+ double-
positive population expressed the cNK cell marker
CD62L and the ILC1 marker TNF-related apoptosis-
inducing ligand (TRAIL) at intermediate levels
(Figure 4d), suggesting they may represent a
transitionary population between cNK cells and
ILC1s.
Systemic cNK cell and ILC1 depletion do not
affect blood parasitaemia
We next investigated the role of ILC1s during
Plasmodium infection, given their transcriptional
and functional resemblance to Th1 cells,1,6 and
previous reports indicating important roles for NK
cells during PcAS infection.25 WT, Rag1/ and
Rag2/cc
/ mice were infected with PcAS, which
caused a nonlethal, chronic infection in control WT
mice.33 Unexpectedly, immunodeficient Rag2/
cc
/ mice (deficient in all lymphocytes) had a
delayed peak parasitaemia, compared to Rag1/
Table 1. Frequencies and total cell numbers of innate lymphoid cells and innate-like T cells
Cell population
% of PBMCs Cell number
Naive D14 Naive D14
CD56- CD127+ ILC1s 0.201  0.043a 7.657  1.473* 3458  803 113 068  21 815*
CD56+ CD127+ ILC1s 0.351  0.060 0.497  0.100 5955  1084 7699  1786
ILC2s 0.005  0.001 0.024  0.006* 88  20 348  83*
ILC3s 0.075  0.012 0.147  0.019* 1311  263 2226  326
NK cells 8.555  1.922 10.073  3.126 144 535  29 365 144 678  44 178
iNKT cells 0.071  0.019 0.040  0.006 1262  374 587  88*
cd T cells 3.042  0.629 4.957  0.898* 50 915  10 533 77 968  14 438*
MAIT cells 1.245  0.578 1.514  0.747 22 785  11 294 23 625  11 166
IFNc+ CD56 CD127+ ILC1s 0.147  0.037 0.374  0.069* 2521  640 5670  1142
IFNc+ CD56+ CD127+ ILC1s 0.162  0.038 0.390  0.095 2762  592 6024  1661
IL-13+ ILC2s 0.002  0.001 0.004  0.001 42  14 59  13
IL-22+ ILC3s 0.007  0.002 0.017  0.005 103  22 238  53
IFNc+ NK cells 3.670  1.041 4.763  1.585 61 618  16 064 67 648  22 301
IFNc+ iNKT cells 0.017  0.005 0.008  0.001 313  119 124  17
IFNc+ cd T cells 1.664  0.413 3.338  0.667* 28 636  7363 52 038  10 180*
IFNc+ MAIT cells 0.643  0.379 0.684  0.309 12 025  7268 10 625  4641
aMean  standard error of mean (SEM) of n = 6 from one cohort treated with artefenomel (OZ439) on day 7 (D7) post-infection.
*P value < 0.05.
Comparisons between days 0 (naive) and 14 (D14) were made using the Wilcoxon (paired, nonparametric) test.
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Figure 2. ILC1s decrease in number and frequency 5 days postinfection with PcAS. The gating strategy to identify liver ILC1s, a population that
is absent in the spleen is shown (a), as well as a summary of the gating strategy for splenic ILC1s (b). These are representative plots from na€ıve
animals. Liver and spleen single-cell suspensions in na€ıve and PcAS-infected mice were stained to determine ILC1 frequencies and cell numbers at
days 1–5, 14 and 28 postinfection. Liver ILC1 (c), splenic ILC1 (d) and liver cNK (e) frequencies and absolute numbers are shown. Data are
representative of two experiments from cohorts of at least n = 4 mice per time point. Comparisons were made using the Kruskal–Wallis test
accompanied by the Dunn’s multiple comparisons test. *P < 0.05, **P < 0.01.
2018 | Vol. 7 | e1003
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mice that were only deficient in B and T cells
(Figure 5a). To determine whether the delayed
peak parasitaemia observed in Rag2/cc
/ mice
could be attributed to the absence of cNKs, we
infected Ncr1-iCre x Mcl1 fl/fl mice with PcAS.
Myeloid cell leukaemia sequence-1 (Mcl1) is critical
for the maintenance of mature NK cells and ILC1s.42
Therefore, these cells were absent in mice lacking
Mcl gene expression in NKp46 (encoded by the
Ncr1 gene)-positive cells. Surprisingly, these mice
were able to control parasite growth and had
similar blood parasitaemia to Ncr1-iCre+/ control
mice (Figure 5b). Hence, the delay in peak
parasitaemia in Rag2/cc
/ mice, relative to
Rag1/ mice, was not likely caused by the absence
of NK cells or ILC1s but instead, possibly reflects
changes in either the activity of phagocytic cells or
alterations to parasite growth in the blood of
Rag2/cc
/mice.
We next focused attention specifically on ILC1s
by infecting Ncr1-iCre x Tgfbr2 fl/fl mice with PcAS.
These mice lack Tgfbr2 gene expression in NKp46-
positive cells and have significantly reduced ILC1
numbers.6 Despite this, these mice were still able to
control parasite growth as efficiently as control
animals (Figure 5c). Given previous contradictory
reports on the role of cNK cells during malaria,25–29
we next confirmed the above results in 2 other cNK
cell- and ILC1-deficient models. First, we treated
mice with a-NK1.1 mAb (depletes cNK cell and
ILC1s) and found no effect on the ability to control
parasite growth, compared with control mice
(Figure 5d). Second, we used diphtheria toxin (DT)
to deplete cNK cells and ILC1s in Ncr1-iCre x iDTR
mice and again found no change in the ability of
mice to control infection, relative to control-
treated animals (Figure 5e). Together, these data
indicate limited roles for cNK cells and ILC1s in
antiparasitic immunity during PcAS infection.
DISCUSSION
Here, we show a reduction in the frequency of
circulating ILC1s, NK cells and innate-like T cells in
healthy volunteers infected for the first time with
Pf. This finding was akin to the decrease in
frequencies and numbers of peripheral T cells
during acute Pf malaria in Ghanaian children.43
Similar observations were made for spleen and
liver ILC1s in C57BL/6 mice infected with PcAS,
accompanied by increased apoptosis in the latter
cell population. Further studies on the roles of
Figure 3. Liver ILC1s exhibit a more apoptotic phenotype than cNK cells. Liver single-cell suspensions were stained for a viability marker, ILC1
surface markers, followed by staining for Caspase-3/7. The representative plots from na€ıve and day 2 p.i. are shown (a) where viability dye+ Caspase-
3/7 = dead cells, viability dye+ Caspase-3/7+ = necrotic cells, (b) viability dye Caspase-3/7+ = apoptotic cells, and viability dye Caspase-3/7 =
live cells. The relative frequencies of viable, apoptotic and necrotic/end-stage apoptotic ILC1s are shown. Data represent mean  SEM from one
experiment where n = 3 for na€ıve mice and n = 4 for PcAS-infected mice. Comparisons were made using the Kruskal–Wallis test accompanied by the
Dunn’s multiple comparisons test. **P < 0.01.
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ILC1s and NK cells during PcAS infection using cell
depletion and genetically modified mice indicated
a limited role for these cells in the control of
blood parasitaemia. These results contrast earlier
findings that reported NK cells confer protection
during Plasmodium infection using anti-asialo
GM1 to deplete NK cells,25 but were consistent
with more recent findings using anti-NK1.1 mAb
for NK cell depletion.28 Interestingly, a recent
study in humans who had received a bone
marrow transplant found that ILCs were
redundant in the presence of competent B and T
cells.5 Our data indicate this may also be the case
in experimental malaria, but we cannot yet make
definitive conclusions on the role of these cells in
human malaria.
A recent study has reported that ILCs were
irreversibly lost during acute HIV-1 infection.44
Our findings in PcAS-infected mice indicate that
liver and splenic ILC1s were lost in the first 5 days
of infection but recovered as infection was
controlled. Similarly, in volunteers participating in
CHMI studies, the frequency and number of
circulating ILC1s, NK cells and innate-like T cells all
fell in the first 7 days of Pf infection but
recovered after drug treatment. This recovery may
have been driven, at least in part, by increased
levels of parasite molecules being available after
drug-mediated killing to promote activation and/
or expansion of certain immune cell subsets.
Nevertheless, changes in these cell populations
during malaria were transient, possibly reflecting
the less persistent nature of Plasmodium infection,
compared to HIV. Of note, we cannot exclude the
possibility that reduced levels of circulating ILC1s,
NK cells, and innate-like T cells following Pf
Figure 4. A novel CD49a+ DX5+ population emerges. Representative plots show a novel CD49a+ DX5+ double-positive population in the liver (a)
and spleen (b) of infected mice. The double-positive population underwent changes during infection (c). Expression of TNF-related apoptosis-
inducing ligand (TRAIL) and CD62L by the CD49a+ DX5+ double-positive population is shown (d). Data are representative of three experiments
from cohorts of at least n = 4 mice.
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infection or ILC1s following PcAS infection might
reflect infection-mediated changes in the marker
expression used to define our cell populations
and/or sequestration of cells in tissues. This will
require further examination.
We identified a cell population in the mouse
liver that expressed both CD49a (an ILC1 marker)
and DX5 (a cNK cell marker). This population was
also NK1.1- and NKp46-positive and expressed
intermediate levels of TRAIL (expressed by ILC1s
but not cNK cells) and CD62L (expressed by cNK
cells but not ILC1s). These CD49a+ DX5+ double-
positive cells emerged at 5 days p.i., which
coincided with the loss of liver ILC1s. They were
Figure 5. Depletion of cNK cells and ILC1s does not affect parasitaemia. C57BL/6J, Rag1/ and Rag2/cc
/ mice were infected with PcAS,
and the kinetics of infection was measured (a). The kinetics of PcAS infection of Ncr1-icre x Mcl1 fl/fl (b) and Ncr1-icre x Tgfbr2fl/fl (c) mice was
compared to that of Ncr1-icre and Ncr1-icre YFP+ control mice, respectively. The kinetics of PcAS infection was also measured after
administration of the monoclonal antibody (mAb) towards NK1.1 (a-NK1.1; clone: PK136) (d). Kinetics of parasitaemia in Ncr1-icre x iDTR mice
administered with diphtheria toxin is shown alongside the kinetics of parasitaemia for C57BL/6J control mice (e). Data in a represent results from
three independent experiments with the peak parasitaemia of Rag1/, and Rag2/cc
/ mice compared using the Mann–Whitney unpaired
(nonparametric) t-test. Data in b, c, d represent results from one experiment. Error bars represent mean  SEM. **P < 0.01.
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also increased in frequency at 14 days p.i., when
liver ILC1 frequency had yet to recover but were
reduced at 28 days p.i., when the relative
proportion of liver ILC1s to cNK cells resembled
proportions prior to the loss of liver ILC1s. These
cells were not liver-specific, as they were also
found in the spleen. A recent report proposed a
bidirectional plasticity between cNKs and ILC1s
that was mediated by the presence or absence of
Eomesodermin (Eomes).45 Our current findings
suggest that this CD49a+ DX5+ double-positive cell
population may be an intermediate population
between cNK cells and ILC1s. Recently, we
reported a similar cell population expressing
CD49a, CD49b and Eomes in mouse tumour
models, and this was found to represent an
intermediate population between TGFb-mediated
conversion of cNK cells into ILC1s.46 Whether this
plasticity between cNKs and ILC1s also occurs in
malaria remains unknown but perturbation of
TGFb signalling following infection could help
explain the disparity between ILC1 and NK cell
frequencies after PcAS infection.
Although our results from mouse models of
malaria indicate a limited role for cNK cells and
ILC1s in control of parasite growth, we cannot
exclude a role for these cells in human malaria,
based on our data. Previous studies have shown
that human NK cells rapidly produce IFNc
following exposure to Pf parasitised red blood
cells (pRBCs) in vitro.29,47 Furthermore, depletion
of NK cells in humanised mice infected with Pf
using anti-CD56 mAb resulted in increased
parasite growth,48 albeit parasite growth
appeared relatively modest in this model system.
Nevertheless, our investigation of associations
between cNK cells, ILC and innate-like T-cell
subsets and either parasite burden (AUC) or PMR
revealed no relationships. Further research is
clearly needed in this area.
Our CHMI and mouse studies were initiated via
an intravenous infusion of blood stage parasites,
thereby bypassing the liver stage of infection.
One advantage of this is that infections are
relatively synchronous and hence, early changes in
immune cell populations can be readily detected.
However, it is possible that host responses to liver
stage infections may influence subsequent
responses to blood stage infections.49 Recently, a
study of innate-like T cells in CHMI studies in
Tanzania using Pf sporozoites to establish
infection reported changes in the frequencies of
circulating NK and MAIT cells up to 6 months
after infection, although reduced frequencies of
MAIT and NK cells were observed before this time
point.32 The earliest samples were taken 9 days
after infection in this study, making comparisons
with our data difficult. Furthermore, the initiation
of infection via liver stage, different parasite dose
used to establish blood stage infection and the
immune status of the Tanzanian volunteers living
in a malaria-endemic region make direct
comparisons with our data challenging.
Nevertheless, comparisons between CHMI studies
initiated with sporozoites and blood stage
parasites in healthy volunteers and those living in
malaria-endemic areas are likely to provide a
wealth of future data that may help explain the
roles of various immune cell populations during
infection and disease, especially if infections
initiated by liver and blood stages can be directly
compared in the same populations.
In conclusion, we report a decline in the
frequency of cNK cells, ILC1s, and innate-like
T cells 7 days after blood stage Pf infection in
CHMI studies with healthy volunteers. A similar
observation was made for liver ILC1s in a mouse
model of malaria caused by PcAS. Our data
indicate a limited role for cNK cells and ILCs in the
control of blood parasitaemia in mice. Together,
these data provide novel insights into the
responses of innate immune cells in mice and
humans during malaria and may help guide
future strategies aimed at manipulating host
immune responses for clinical advantage during
this disease.
METHODS
Controlled human malaria infection
Experimental procedures were performed as part of a
substudy on human blood samples collected from
consenting participants enrolled in a drug study (Australian
New Zealand Clinical Trials Registry ACTRN12613000565741
and NCT02389348) conducted at Q-Pharm Pty Ltd (Herston,
QLD, Australia) under the approval of the QIMR Berghofer
Medical Research Institute Human Research Ethics
Committee (QIMR-HREC). Volunteers comprised healthy
male and female nonsmokers, aged between 18 and 45 in
one trial and 18 and 55 in another trial, with no history of
malaria or prior exposure to malaria-endemic regions.
Experiments were performed on blood samples collected
from participants enrolled in 3 cohorts (n = 14 volunteers in
total). An additional cohort (n = 8 volunteers) was used to
examine NK cell frequency and number. Participants were
infected intravenously using a Pf (clone 3D7)-induced blood
stage malaria (IBSM) challenge inoculum (1800 parasitised
2018 | Vol. 7 | e1003
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red blood cells [pRBC]), with parasitaemia monitored by real-
time quantitative polymerase chain reaction (qPCR),50–52 and
blood collected at time points indicated in Results section.
Antimalarial drug treatment was administered once
parasitaemia exceeded 1000 parasites per mL.
Parasitaemia was plotted over time for each patient, and
parasite burden over the course of infection (prior to
treatment) was expressed as a measurement of AUC, as
previously described.19 A growth model was also derived
from parasitaemia measurements (prior to treatment) over
time and fitted to each individual using simple linear
regression. The gradient of this growth model (parasite
multiplication rate [PMR]) was then estimated using a log-
linear model described by the following equation:
log10ð!Þ ¼ aþm time;
where ! is parasites per mL measured by qPCR, a is the
intercept, m is the gradient of the growth model, and time
is the number of days from inoculation.
Isolation of peripheral blood mononuclear
cells from human blood
Approximately 13 mL of blood was collected per volunteer,
per time point, in BD Vacutainer Lithium HeparinN (LH)
170 I.U. Plus Blood Collection Tubes (BD Biosciences, San
Jose, CA, USA). Blood was layered over Ficoll-PaqueTM PLUS
(GE Healthcare, Little Chalfont, Buckinghamshire, UK) to
isolate peripheral blood mononuclear cells (PBMCs). PBMCs
were counted using a hemocytometer.
Mice
Female mice between 8 and 12 weeks old were used. C57BL/
6J (WT) mice were purchased from the Walter and Eliza Hall
Institute (WEHI), Kew, VIC, Australia. Rag1/, Rag2/cc
/,
Ncr1-iCre, Ncr1-iCre x iDTR, Ncr1-iCre YFP+, Ncr1-iCre x
Mcl1 fl/fl and Ncr1-iCre x Tgfbr2 fl/fl mice all on the C57BL/6J
genetic background were bred in house.42,53–61 All mice were
housed under pathogen-free conditions at the QIMR
Berghofer Medical Research Institute Animal Facility
(Herston, QLD, Australia). Experimental use was in
accordance with the ‘Australian Code of Practice for the Care
and Use of Animals for Scientific Purposes’ (Australian
National Health and Medical Research Council) and approved
by the QIMR Berghofer Medical Research Institute Animal
Ethics Committee (Herston, QLD, Australia; approval number:
A02-633M).
PcAS infections and measurement of
peripheral blood parasitaemia
PcAS was thawed from stabilities and passaged once in vivo
in a C57BL/6J mouse, prior to establishing experimental
infections. Mice were infected intravenously (i.v.) with 105
pRBCs. Parasitaemia was measured by flow cytometry using
Hoechst 33342 (Sigma-Aldrich, St. Louis, MO, USA) and
Syto 84 (InvitrogenTM, Life Technologies, Carlsbad, CA, USA),
as previously described.62 Samples were acquired on a BD
FACSCantoTM II through BD FACSDivaTM V8.0 (both by BD
Biosciences) and analysed on FlowJo v10 OSX (Tree Star,
Inc., Ashland, OR, USA).
Preparation of spleen and liver single-cell
suspensions
Mice were sacrificed by CO2 asphyxiation. A mid-sagittal
incision was made on the abdominal cavity. The spleen was
removed and passed through a 100-lm cell strainer (Corning
Incorporated, Corning, NY, USA). The single-cell suspension
was washed in Roswell Park Memorial Institute Medium
(RPMI; Life Technologies) + 100 lg mL1 penicillin and
streptomycin (ps; Gibco, Life Technologies) (RPMI/ps) and
incubated for 7 min in Red Blood Cell Lysis Buffer Hybri-
MaxTM (Sigma-Aldrich). Cells were washed in RPMI/ps,
pelleted by centrifugation and counted on the Countess II FL
(Life Technologies), as per manufacturer’s protocol. The liver
was perfused with 19 phosphate-buffered saline (PBS). The
excised liver was collected in 1% (v/v) foetal bovine serum
(FBS) in PBS and mechanically passed through a 200-lm
square metal mesh. Hepatocytes were separated from
lymphocytes and removed using a 33% PercollTM (GE
Healthcare) gradient according to manufacturer’s
instructions. Red Blood Cell Lysis Buffer Hybri-MaxTM was
added to each pellet and incubated for 5 min at room
temperature, prior to washing in 1% (v/v) FBS in PBS. Cells
were pelleted by centrifugation and counted using the
Countess II FL, as per manufacturer’s protocol.
Identification of spleen and liver ILC1s
using flow cytometry
Freshly prepared spleen and liver single-cell suspensions were
incubated for 20 min with TruStain fcXTM (anti-mouse CD16/
32; 93) and Zombie AquaTM Fixable Viability Kit (both from
BioLegend, SanDiego, CA, USA) at room temperature. Cells
were subsequently stained with a cell lineage cocktail
containing biotin-conjugated anti-mouse CD3e (145-2C11),
CD5 (53–7.3) and CD19 (6D5) (all from BioLegend) at room
temperature. Lineage-negative cells in splenocytes were
concentrated by negative selection using the EasySepTM
Biotin Positive Selection Kit (STEMCELL TechnologiesTM,
Vancouver, Canada) according to manufacturer’s
instructions. Surface staining included fluorophore-
conjugated streptavidin (BioLegend) and fluorophore-
conjugated anti-mouse monoclonal antibodies (mAb) against
CD45 (30-F11), NK1.1 (PK136), NKp46 (29A1.4), CD49a
(HMa1), CD49b (DX5), CD62L (MEL-14) (all from BioLegend)
and TRAIL (CD253, N2B2) (eBioscience, San Diego, CA, USA).
Identification of human circulatory ILC1s in
PBMCs
Freshly isolated PBMCs (2 9 107) were incubated for 3 h
with Phorbol 12-myristate 13-acetate (PMA) and ionomycin
calcium salt (both from Sigma-Aldrich) in complete media
(RPMI/ps + 10% (v/v) FBS) with BD GolgiPlugTM Protein
Transport Inhibitor and BD GolgiStopTM Protein Transport
Inhibitor (containing Monensin) (both by BD Biosciences) at
37°C. PBMCs were then incubated with a cell lineage
ª 2018 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
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cocktail containing fluorescein isothiocyanate (FITC)-
conjugated mouse anti-human mAbs against CD123 (6H6),
TCRa/b (IP26), TCRc/d (B1), CD14 (HCD14), CD34 (561), CD19
(HIB19) (BioLegend). PBMCs were incubated with a goat
anti-mouse IgG biotinylated affinity-purified polyclonal
antibody (R&D SystemsTM by Bio-Techne, Minneapolis,
Minnesota, USA). Lineage-negative (Lin) cells were
isolated using the EasySepTM Biotin Positive Selection Kit
(STEMCELL TechnologiesTM) according to manufacturer’s
instructions.
Lineage-negative cells were stained with a surface cocktail
containing fluorophore-conjugated anti-human mAbs
towards: CD56 (NCAM; HCD56), CD25 (BC96), Zombie AquaTM
Fixable Viability Kit, CD69 (FN50), and CD127 (A019D5) (all
from BioLegend). Cells were then incubated with the Foxp3/
Transcription Factor Staining Buffer Set (eBioscience) reagents
according to manufacturer’s instructions, followed by
intracellular staining with an antibody cocktail containing
fluorophore-conjugated anti-human mAbs against T-bet
(4B10) (eBioscience) and IFNc (4S.B3) (BioLegend).
Identification of human innate-like T cells in
PBMCs
PBMCs (5 9 105) were incubated for 3 h with PMA and
ionomycin calcium salt in complete media with BD
GolgiPlugTM Protein Transport Inhibitor and BD GolgiStopTM
Protein Transport Inhibitor (containing Monensin) at 37°C.
PBMCs were stained with a surface cocktail containing
fluorophore-conjugated anti-human mAbs against CD3e
(UCHT1) (both from BD PharmingenTM, BD Biosciences), CD127
(A019D5), CD19 (HIB19) and CD56 (HCD56) (all from
BioLegend) or a separate cocktail containing fluorophore-
conjugated anti-human mAbs against CD161 (DX12) and
CD3e (UCHT1) (both from BD PharmingenTM, BD Biosciences),
CD4 (RPA-T4), CD8a (SK1), Zombie AquaTM Fixable Viability
Kit, TCR Va7.2 (3C10), TCRc/d (B1) (all from BioLegend) and
human a-GalCer-loaded-CD1d PBS44 tetramer. In brief,
sequences encoding human b2M and the extracellular
domain of human CD1d were cloned into the expression
vector pHLsec and transfected into mammalian HEK-
293S.GnTI cells.63 Human b2M encoding amino acid IQRTP to
RDMGS and human CD1d encoding amino acid VPQRL to
VLYWGS with a c-terminal BirA tag and His tag (amino
sequence GLNDIFEAQKIEWHEHHHHHH) were purified using
Nickel agarose purification and biotinylated using BirA
enzyme. Biotinylated CD1d was loaded with PBS-44 provided
by Paul Savage (Brigham Young University, Provo, UT) and
converted to tetramers by the addition of streptavidin BV421
(eBioscience).
Cells were incubated with the Foxp3/Transcription Factor
Staining Buffer Set (eBioscience) reagents according to
manufacturer’s instructions, followed by intracellular staining
with an antibody cocktail containing fluorophore-conjugated
anti-human mAbs towards PLZF (R17-809) and/or IFNc (4S.B3)
(both from BD PharmingenTM).
Flow cytometry
Samples were resuspended in 1% (w/v) paraformaldehyde
(PFA) poststaining and stored at 4°C before acquisition on a
BD LSRFortessaTM (special order research product; BD
Biosciences) through BD FACSDivaTM V8.0 and analysed on
FlowJo v10 OSX.
Detection of apoptotic cells
Apoptotic cells were detected by cell surface staining with
either Annexin V from the Annexin V FITC Apoptosis
Detection Kit I (BD Biosciences) or reagents from the
CellEvent Caspase-3/7 Green Flow Cytometry Assay Kit
(Molecular Probes, Life Technologies), as per
manufacturer’s instructions.
Depletion of cNKs and ILC1s
C57BL/6J or Rag1/ mice were given an intraperitoneal
(i.p.) injection with 1 mg per mouse of either anti-NK1.1
(PK136) mAb or InVivo MAb Polyclonal Mouse IgG (both
from BioXCell, West Lebanon, New Hampshire, USA) on
alternate days, starting from the day before infection.
Ncr1-iCre x iDTR mice were given 8 ng g1 (based on body
weight) of DT from Corynebacterium diphtheria (Sigma-
Aldrich) per mouse 2 days and 1 day prior to infection and
every 2 days after infection. Control mice were given an
equal volume of sodium chloride (0.9% [w/v]) for irrigation
(Baxter International, Deerfield, IL, USA). Depletion efficacy
in both models was determined by flow cytometry analysis
using an anti-mouse mAb towards NKp46 (CD335; 29A1.4)
(BioLegend).
Statistics
Graphing and statistical analyses were performed on
GraphPad Prism 6 (GraphPad, San Diego, CA, USA). A
P-value (P) < 0.05 was considered statistically significant.
Direct comparisons between two time points in the human
trial data were made using the Wilcoxon (paired,
nonparametric) test. For studies involving mice, comparisons
between time points in time course experiments were made
using the Kruskal–Wallis test accompanied by the Dunn’s
multiple comparisons test, while comparisons between two
groups of mice were made using the Mann–Whitney
(unpaired, nonparametric) t-test. All data are shown as
mean  standard error of mean (SEM) unless otherwise
stated.
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